The soluble interleukin-2 receptor in rheumatic disease
β Scribed by Laurence A. Rubin
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 339 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Objective: To investigate the presence and the roles of anti-interleukin-6 (anti-il-6) autoantibodies in rheumatic diseases, and to further elucidate clinical and pathophysiologic significance of anticytokine autoantibodies. ## Methods: Anti-il-6 igg autoantibodies were measured by the 125i-il
Background. Serum concentrations of soluble interleukin-2 receptor (IL-2R) were found to be high in patients with autoimmune diseases, lung cancer, malignant lymphoma, tuberculosis, and other diseases. Serum-soluble IL-2R was evaluated as a tumor maker in patients with gastric cancer. Methods. Preo
Soluble interleukin-2 receptor (sIL-2R) was measured in the plasma of 31 patients with idiopathic thrombocytopenic purpura (ITP) and 22 normal controls. When thrombocytopenia persisted longer than 6 months, the diagnosis of chronic ITP was made. Twenty patients had acute ITP, 11 patients had chronic